The present invention provides a partial peptide consisting of 8-11
contiguous amino acids in the amino acid sequence of livin set forth in
SEQ ID NO: 1, which binds to HLA-A24 antigen and is recognized by
cytotoxic T cells (CTLs), a polynucleotide encoding the peptide, and
cancer vaccine comprising the peptide or the polynucleotide.